PT2231689T - Novos nucleósidos 7-deazapurina citostáticos - Google Patents

Novos nucleósidos 7-deazapurina citostáticos

Info

Publication number: PT2231689T
Authority: PT; Portugal
Prior art keywords: deazapurine nucleosides; novel cytostatic; cytostatic; novel; deazapurine
Prior art date: 2008-01-18

Application number

PT97028427T

Other languages

English (en)

Inventor

Hocek Michal

Naus Petr

Original Assignee

Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-18

Filing date

2009-01-15

Publication date

2016-10-07

2009-01-15 Application filed by Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic filed Critical Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic

2016-10-07 Publication of PT2231689T publication Critical patent/PT2231689T/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/00032—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries characterised by data exchange
- H02J7/00036—Charger exchanging data with battery
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/00047—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries with provisions for charging different types of batteries

Landscapes

Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Power Engineering (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PT97028427T 2008-01-18 2009-01-15 Novos nucleósidos 7-deazapurina citostáticos PT2231689T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2224708P	2008-01-18	2008-01-18

Publications (1)

Publication Number	Publication Date
PT2231689T true PT2231689T (pt)	2016-10-07

Family

ID=40434932

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT16174985T PT3133080T (pt)	2008-01-18	2009-01-15	Nucleósidos de 7-deazapurina citostáticos inovadores
PT97028427T PT2231689T (pt)	2008-01-18	2009-01-15	Novos nucleósidos 7-deazapurina citostáticos

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT16174985T PT3133080T (pt)	2008-01-18	2009-01-15	Nucleósidos de 7-deazapurina citostáticos inovadores

Country Status (18)

Country	Link
US (1)	US8093226B2 (pt)
EP (2)	EP2231689B1 (pt)
JP (2)	JP5485172B2 (pt)
CN (1)	CN101977923B (pt)
AU (1)	AU2009204568B2 (pt)
CA (1)	CA2711384C (pt)
CY (2)	CY1118104T1 (pt)
DK (2)	DK3133080T3 (pt)
ES (2)	ES2693551T3 (pt)
HR (2)	HRP20161344T1 (pt)
HU (2)	HUE041598T2 (pt)
LT (2)	LT2231689T (pt)
NZ (1)	NZ586610A (pt)
PL (2)	PL2231689T3 (pt)
PT (2)	PT3133080T (pt)
SI (2)	SI3133080T1 (pt)
TR (1)	TR201815961T4 (pt)
WO (1)	WO2009089804A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2543904T3 (es)	2005-12-13	2015-08-25	Incyte Corporation	Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus
EP4011883A1 (en)	2007-06-13	2022-06-15	Incyte Holdings Corporation	Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3-cyclopentylpropanenitrile
CL2009001884A1 (es) *	2008-10-02	2010-05-14	Incyte Holdings Corp	Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
DK2421879T3 (da) *	2009-04-22	2013-11-25	Acad Of Science Czech Republic	Nye 7-deazapurinnukleotider til terapeutiske anvendelser
WO2010135650A1 (en)	2009-05-22	2010-11-25	Incyte Corporation	N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
SI2432472T1 (sl)	2009-05-22	2019-11-29	Incyte Holdings Corp	3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
TW201113285A (en)	2009-09-01	2011-04-16	Incyte Corp	Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
NZ602313A (en)	2010-03-10	2014-08-29	Incyte Corp	Piperidin-4-yl azetidine derivatives as jak1 inhibitors
MY161078A (en)	2010-05-21	2017-04-14	Incyte Holdings Corp	Topical formulation for a jak inhibitor
AU2011330730B2 (en) *	2010-11-18	2016-02-18	Kasina Laila Innova Pharmaceuticals Private Limited	Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
JP5917545B2 (ja)	2010-11-19	2016-05-18	インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅＨｏｌｄｉｎｇｓＣｏｒｐｏｒａｔｉｏｎ	Ｊａｋ阻害剤としてのシクロブチル置換ピロロピリジンおよびピロロピリミジン誘導体
US9034884B2 (en)	2010-11-19	2015-05-19	Incyte Corporation	Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
CN103797010B (zh)	2011-06-20	2016-02-24	因塞特控股公司	作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
TW201313721A (zh)	2011-08-18	2013-04-01	Incyte Corp	作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk)	2011-09-07	2016-06-24	Інсайт Холдінгс Корпорейшн	Способи і проміжні сполуки для отримання інгібіторів jak
TW201406761A (zh)	2012-05-18	2014-02-16	Incyte Corp	做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
US10166191B2 (en)	2012-11-15	2019-01-01	Incyte Corporation	Sustained-release dosage forms of ruxolitinib
UA121532C2 (uk)	2013-03-06	2020-06-10	Інсайт Холдінгс Корпорейшн	Способи і проміжні сполуки при отриманні інгібітора jak
CN116036089A (zh)	2013-08-07	2023-05-02	因赛特控股公司	Jak1抑制剂的持续释放剂型
WO2015184305A1 (en)	2014-05-30	2015-12-03	Incyte Corporation	TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
JP6650074B2 (ja)	2016-06-29	2020-02-19	ウスタフオルガニッケヘミエアービオヘミエアカデミエヴェドツェーエル，ヴェー．ヴェー．イー	治療に使用するための、置換チエノピロロピリミジンリボヌクレオシド
CZ307334B6 (cs)	2016-08-02	2018-06-13	Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i.	Substituované heteropentadieno-pyrrolopyrimidinové ribonukleosidy pro terapeutické použití
WO2019113487A1 (en)	2017-12-08	2019-06-13	Incyte Corporation	Low dose combination therapy for treatment of myeloproliferative neoplasms
CR20200379A (es)	2018-01-30	2021-03-05	Incyte Corp	Procesos e intermedio para elaborar un inhibidor de jak campo técnico
CZ308104B6 (cs)	2018-03-12	2020-01-08	Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i.	Pyridinopyrrolopyrimidinové ribonukleosidy pro terapeutické použití
AU2019245420B2 (en)	2018-03-30	2024-10-10	Incyte Corporation	Treatment of hidradenitis suppurativa using JAK inhibitors
EP3952874A4 (en) *	2019-04-05	2022-12-28	Prelude Therapeutics, Incorporated	SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
PH12021553139A1 (en) *	2019-06-18	2022-07-25	Taiho Pharmaceutical Co Ltd	Novel carbonate compound having pyrrolopyrimidine skeleton or pharmaceutically acceptable salt thereof
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms
CN112190590A (zh) *	2020-11-06	2021-01-08	牡丹江医学院	一种治疗动脉粥样硬化的硒核苷及其药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS50125033A (pt) *	1974-03-19	1975-10-01
IL108523A0 (en)	1993-02-03	1994-05-30	Gensia Inc	Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
JPH10158293A (ja) *	1996-08-08	1998-06-16	Rikagaku Kenkyusho	３’−デオキシリボヌクレオチド誘導体
JP3489991B2 (ja) *	1997-07-07	2004-01-26	理化学研究所	３’−デオキシリボヌクレオチド誘導体
JP3318579B2 (ja) *	1997-07-07	2002-08-26	理化学研究所	Ｄｎａの塩基配列決定方法
CZ9901996A3 (cs) *	1999-06-04	2001-01-17	Ústav organické chemie a biochemie AV ČR	Nové 6-fenylpurinové 9-ß-D-ribonukleosidy s antineoplastickým účinkem, jejich použití k přípravě farmaceutických preparátů a farmaceutické přípravky, které je obsahují
AU2002353165A1 (en) *	2001-12-17	2003-06-30	Ribapharm Inc.	Deazapurine nucleoside libraries and compounds
CN1863813B (zh) *	2003-08-27	2011-03-30	生物区科学管理控股有限公司	作为治疗剂的三环核苷或核苷酸
JP2008517912A (ja) *	2004-10-21	2008-05-29	メルクエンドカムパニーインコーポレーテッド	ＲＮＡ依存性ＲＮＡウイルス感染治療用フッ素化ピロロ［２，３−ｄ］ピリミジンヌクレオシド
CN101043893A (zh) *	2004-10-21	2007-09-26	默克公司	治疗RNA－依赖性RNA病毒感染的氟化吡咯并[2,3－d]嘧啶核苷
AR056327A1 (es) *	2005-04-25	2007-10-03	Genelabs Tech Inc	Compuestos de nucleosidos para el tratamiento de infecciones virales

2009
- 2009-01-15 SI SI200931882T patent/SI3133080T1/sl unknown
- 2009-01-15 DK DK16174985.8T patent/DK3133080T3/en active
- 2009-01-15 HU HUE16174985A patent/HUE041598T2/hu unknown
- 2009-01-15 US US12/354,432 patent/US8093226B2/en active Active
- 2009-01-15 NZ NZ586610A patent/NZ586610A/xx unknown
- 2009-01-15 PT PT16174985T patent/PT3133080T/pt unknown
- 2009-01-15 EP EP09702842.7A patent/EP2231689B1/en active Active
- 2009-01-15 ES ES16174985.8T patent/ES2693551T3/es active Active
- 2009-01-15 TR TR2018/15961T patent/TR201815961T4/tr unknown
- 2009-01-15 JP JP2010542509A patent/JP5485172B2/ja active Active
- 2009-01-15 EP EP16174985.8A patent/EP3133080B1/en active Active
- 2009-01-15 AU AU2009204568A patent/AU2009204568B2/en active Active
- 2009-01-15 PT PT97028427T patent/PT2231689T/pt unknown
- 2009-01-15 LT LTEP09702842.7T patent/LT2231689T/lt unknown
- 2009-01-15 HU HUE09702842A patent/HUE030767T2/en unknown
- 2009-01-15 PL PL09702842T patent/PL2231689T3/pl unknown
- 2009-01-15 DK DK09702842.7T patent/DK2231689T3/en active
- 2009-01-15 ES ES09702842.7T patent/ES2598503T3/es active Active
- 2009-01-15 PL PL16174985T patent/PL3133080T3/pl unknown
- 2009-01-15 LT LTEP16174985.8T patent/LT3133080T/lt unknown
- 2009-01-15 CA CA2711384A patent/CA2711384C/en active Active
- 2009-01-15 SI SI200931535A patent/SI2231689T1/sl unknown
- 2009-01-15 CN CN200980109880.3A patent/CN101977923B/zh active Active
- 2009-01-15 WO PCT/CZ2009/000004 patent/WO2009089804A1/en active Application Filing
2013
- 2013-12-25 JP JP2013266910A patent/JP2014058567A/ja not_active Withdrawn
2016
- 2016-10-14 HR HRP20161344TT patent/HRP20161344T1/hr unknown
- 2016-10-19 CY CY20161101041T patent/CY1118104T1/el unknown
2018
- 2018-10-29 HR HRP20181774TT patent/HRP20181774T1/hr unknown
- 2018-10-30 CY CY20181101120T patent/CY1121364T1/el unknown

Also Published As

Publication number	Publication date
HRP20161344T1 (hr)	2016-11-18
HUE030767T2 (en)	2017-05-29
CA2711384C (en)	2016-07-26
EP3133080A1 (en)	2017-02-22
ES2693551T3 (es)	2018-12-12
EP2231689B1 (en)	2016-07-20
AU2009204568B2 (en)	2013-10-03
PL3133080T3 (pl)	2018-12-31
JP2011509949A (ja)	2011-03-31
JP2014058567A (ja)	2014-04-03
NZ586610A (en)	2012-08-31
DK2231689T3 (en)	2016-09-19
EP2231689A1 (en)	2010-09-29
EP3133080B1 (en)	2018-08-01
ES2598503T3 (es)	2017-01-27
SI2231689T1 (sl)	2016-11-30
CA2711384A1 (en)	2009-07-23
DK3133080T3 (en)	2018-11-26
HRP20181774T1 (hr)	2018-12-28
CN101977923B (zh)	2014-10-08
HUE041598T2 (hu)	2019-05-28
US8093226B2 (en)	2012-01-10
AU2009204568A1 (en)	2009-07-23
CN101977923A (zh)	2011-02-16
LT2231689T (lt)	2016-10-25
PT3133080T (pt)	2018-11-16
WO2009089804A1 (en)	2009-07-23
TR201815961T4 (tr)	2018-11-21
SI3133080T1 (sl)	2018-12-31
CY1121364T1 (el)	2020-05-29
CY1118104T1 (el)	2017-06-28
PL2231689T3 (pl)	2017-01-31
US20090203637A1 (en)	2009-08-13
JP5485172B2 (ja)	2014-05-07
LT3133080T (lt)	2018-11-12

Publication	Publication Date	Title
HRP20181774T1 (hr)	2018-12-28	Novi citostatski 7-deazapurinski nukleosidi
HRP20171398T1 (hr)	2017-11-03	Novi derivati adenina
HK1209129A1 (en)	2016-03-24	Novel 7-deazapurine nucleosides for therapeutic uses 7-
ZA201008829B (en)	2011-09-28	Nucleoside cyclicphosphates
IL213698A0 (en)	2011-07-31	Nucleoside phosphoramidates
ZA201104638B (en)	2012-11-28	Nucleoside analogs
IL200831A0 (en)	2010-05-17	Novel adenine compounds
IL205625A0 (en)	2010-11-30	Antiviral nucleoside compounds
EP2138497A4 (en)	2012-01-04	NEW ADENINE CONNECTION
IL213701A0 (en)	2011-07-31	Synthesis of purine nucleosides
IL210207A0 (en)	2011-03-31	Compounds having antiviral properties
ZA201103943B (en)	2012-11-28	Purine compounds
GB0803707D0 (en)	2008-04-09	Antiviral agent
GB0723609D0 (en)	2008-01-09	Antiviral
IL207312A0 (en)	2010-12-30	Cytostatic composition
GB0819528D0 (en)	2008-12-03	Antiviral compounds
IL192335A0 (en)	2011-08-01	Antiviral compounds
GB0816600D0 (en)	2008-10-15	Antiviral compounds
GB0704852D0 (en)	2007-04-18	Furanose derivatives
GB0717955D0 (en)	2007-10-24	Preparation of modified nucleosides
GB0803654D0 (en)	2008-04-02	Buster brackets (KA-2 + KA-9)